The honest way to judge recovery from long COVID is to compare objective measures before and after a change, not to rely on how you happen to feel on a given day. That means a baseline, a defined trial period for one intervention, and a retest, tracking your symptoms and, where relevant, inflammation markers so you can tell signal from noise.
Key takeaways
- Long COVID symptoms fluctuate, so "I feel better today" is not reliable evidence that something is working.
- A cleaner approach is baseline, one intervention, then retest, changing one thing at a time.
- Structured symptom tracking (fatigue, post-exertional malaise, brain fog, sleep) is the foundation.
- Some people also track inflammation markers such as IL-6, TNF, and CRP to see whether they move toward the healthy range.
- This is measurement for informational use, to interpret with your doctor, not a diagnosis or a promise of any outcome.
Why is it so hard to tell if long COVID recovery is working?
Long COVID symptoms can emerge, persist, resolve, and reemerge on their own. A good week can follow a bad one for reasons that have nothing to do with what you changed. Add the placebo effect, seasonal shifts, and the natural ups and downs of the illness, and it becomes genuinely difficult to know whether an intervention helped, did nothing, or coincided with a natural upswing. This is the frustration behind so much wasted time and money: people try things, feel a little different, and never really know why.
The fix is not more willpower. It is measurement. When you have data from before and after, you stop guessing.
How do you set up a baseline before changing anything?
A baseline is a snapshot of where you are now, taken before you start something new. A useful baseline captures both how you feel and, if you choose, objective markers:
- Symptom tracking: rate fatigue, post-exertional malaise, cognitive function, sleep quality, and any orthostatic symptoms on a simple scale, most days, for two to four weeks.
- Function: note practical anchors, such as steps taken, hours upright, or how many activities trigger a crash.
- Objective markers: where relevant, record a starting measurement so you have something concrete to compare against later.
The point of a baseline is to protect you from your own recall. Memory of symptoms is unreliable, and a documented starting point is what makes any later comparison meaningful. For a deeper walkthrough, see our guide on how to know if a treatment is working.
What should you actually track during recovery from long COVID?
Track the things that matter to your daily life and the things that can be measured consistently. On the symptom side, a short daily log beats a long one you abandon. On the biology side, some people monitor inflammation-signaling molecules because research has associated persistent long COVID with differences in immune signaling compared with people who recovered.
Markers people commonly follow include IL-6 and TNF (core inflammatory cytokines) and CRP (a general inflammation readout your doctor may already order). The relevant question over time is directional: are these values moving toward the healthy reference range or away from it? Muno Mirror measures a 250-plex inflammation proteomics panel from a small at-home microsample and benchmarks each marker against a healthy reference, and it is built for retesting so you can see change across time points. You can see what Muno Mirror measures and review your results with your own doctor.
How often should you retest to see if something is working?
Retest cadence should match the timescale of what you are trying. Changing one thing and remeasuring a week later rarely tells you much, because biology and symptoms both take time to shift. A more informative rhythm is:
- Establish your baseline first.
- Give a single intervention a defined trial window, often several weeks to a few months, depending on what it is and what your doctor advises.
- Retest at the end of that window, comparing both symptoms and markers to baseline.
- Change only one variable at a time, so any difference is interpretable.
This baseline-intervention-retest loop is what turns "I think this helped" into "here is what changed." It will not, by itself, prove causation, and it is not a diagnosis, but it replaces guessing with something you and your clinician can actually read. If you are trying a specific therapy, our note on what to track with low-dose naltrexone for long COVID shows how to apply this to one example.
Frequently asked questions
How do I know if my long COVID recovery is actually working?
Compare objective, documented measures from before and after a single change, rather than relying on day-to-day feelings. A baseline, a defined trial period, structured symptom tracking, and a retest let you see whether things moved. This shows change; it does not by itself prove what caused it, and it is not a diagnosis.
Do inflammation markers show whether long COVID is improving?
They can add objective context. Some people track markers like IL-6, TNF, and CRP to see whether they move toward the healthy reference range over time. This is informational monitoring to discuss with your doctor, not proof of recovery and not a diagnostic test.
How long should I try one intervention before deciding?
Long enough for a real effect to show, which usually means several weeks to a few months depending on the intervention and your doctor's guidance. Changing one thing at a time and retesting at the end of that window keeps the result interpretable.
Why do long COVID recovery stories vary so much?
Long COVID is heterogeneous, symptoms fluctuate, and people try different things at different points in their illness. What helps one person may do nothing for another. That variability is exactly why individual baselines and retesting are more useful than comparing yourself to someone else's timeline.